Low T3 syndrome is a prognostic marker of poor outcomes in secondary hemophagocytic lymphohistiocytosis

References

• Schram AM, Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood. 2015;125(19):2908–2914.
   PubMed Web of Science ®Google Scholar
• La Rosee P, Horne A, Hines M, et al. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019;133(23):2465–2477.
   PubMed Web of Science ®Google Scholar
• Cattaneo C, Oberti M, Skert C, et al. Adult onset hemophagocytic lymphohistiocytosis prognosis is affected by underlying disease and coexisting viral infection: analysis of a single institution series of 35 patients. Hematol Oncol. 2017;35(4):828–834.
   PubMed Web of Science ®Google Scholar
• Grange S, Buchonnet G, Besnier E, et al. The use of ferritin to identify critically ill patients with secondary hemophagocytic lymphohistiocytosis. Crit Care Med. 2016;44(11):e1045–e1053.
   PubMed Web of Science ®Google Scholar
• Jiang T, Ding X, Lu W. The prognostic significance of beta2 microglobulin in patients with hemophagocytic lymphohistiocytosis. Dis Markers 2016;2016:1–6.
   Web of Science ®Google Scholar
• Park HS, Kim DY, Lee JH, et al. Clinical features of adult patients with secondary hemophagocytic lymphohistiocytosis from causes other than lymphoma: an analysis of treatment outcome and prognostic factors. Ann Hematol. 2012;91(6):897–904.
   PubMed Web of Science ®Google Scholar
• Chopra IJ. Nonthyroidal illness syndrome or euthyroid sick syndrome? Endocr Pract. 1996;2(1):45–52.
   PubMedGoogle Scholar
• Kurt A, Aygun AD, Sengul I, et al. Serum thyroid hormones levels are significantly decreased in septic neonates with poor outcome. J Endocrinol Invest. 2011;34(4):e92–e96.
   PubMed Web of Science ®Google Scholar
• Liu J, Wu X, Lu F, et al. Low T3 syndrome is a strong predictor of poor outcomes in patients with community-acquired pneumonia. Sci Rep. 2016;6(1):22271.
   PubMedGoogle Scholar
• Padhi R, Kabi S, Panda BN, et al. Prognostic significance of nonthyroidal illness syndrome in critically ill adult patients with sepsis. Int J Crit Illn Inj Sci. 2018;8(3):165–172.
   PubMedGoogle Scholar
• de Saint Basile G, Ménasché G, Fischer A. Molecular mechanisms of biogenesis and exocytosis of cytotoxic granules. Nat Rev Immunol. 2010;10(8):568–579.
   PubMed Web of Science ®Google Scholar
• Ramachandran S, Zaidi F, Aggarwal A, et al. Recent advances in diagnostic and therapeutic guidelines for primary and secondary hemophagocytic lymphohistiocytosis. Blood Cells Mol Dis. 2017;64:53–57.
   PubMed Web of Science ®Google Scholar
• Stouthard JM, van der Poll T, Endert E, et al. Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab. 1994;79(5):1342–1346.
   PubMed Web of Science ®Google Scholar
• Hayden A, Park S, Giustini D, et al. Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: a systematic scoping review. Blood Rev. 2016;30(6):411–420.
   PubMed Web of Science ®Google Scholar
• Griffin G, Shenoi S, Hughes GC. Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol. 2020. DOI:10.1016/j.berh.2020.101515.
   PubMed Web of Science ®Google Scholar
• Liang JH, Wang L, Zhu HY, et al. Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial. Haematologica. 2020;105(1):e29–e32.
   PubMed Web of Science ®Google Scholar
• Wang J, Wang D, Zhang Q, et al. The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable. J Cancer Res Clin Oncol. 2016;142(4):859–871.
   PubMed Web of Science ®Google Scholar
• Zhang LJ, Xu J, Liu P, et al. The significance of 18F-FDG PET/CT in secondary hemophagocytic lymphohistiocytosis. J Hematol Oncol. 2012;5:40.
   PubMed Web of Science ®Google Scholar
• Papanicolaou DA. Euthyroid sick syndrome and the role of cytokines. Rev Endocr Metab Disord. 2000;1(1–2):43–48.
   PubMedGoogle Scholar
• Bunevicius A, Deltuva V, Tamasauskas S, et al. Low triiodothyronine syndrome as a predictor of poor outcomes in patients undergoing brain tumor surgery: a pilot study: clinical article. JNS. 2013;118(6):1279–1287.
   PubMed Web of Science ®Google Scholar
• Gao R, Liang JH, Wang L, et al. Low T3 syndrome is a strong prognostic predictor in diffuse large B cell lymphoma. Br J Haematol. 2017;177(1):95–105.
   PubMed Web of Science ®Google Scholar
• Gao R, Chen RZ, Xia Y, et al. Low T3 syndrome as a predictor of poor prognosis in chronic lymphocytic leukemia. Int J Cancer 2018;143(3):466–477.
   PubMed Web of Science ®Google Scholar
• De Groot LJ. Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit Care Clin. 2006;22(1):57–86.
   PubMed Web of Science ®Google Scholar
• de Vries EM, van Beeren HC, Ackermans MT, et al. Differential effects of fasting vs food restriction on liver thyroid hormone metabolism in male rats. J Endocrinol. 2015;224(1):25–35.
   PubMed Web of Science ®Google Scholar
• Fekete C, Gereben B, Doleschall M, et al. Lipopolysaccharide induces type 2 iodothyronine deiodinase in the mediobasal hypothalamus: implications for the nonthyroidal illness syndrome. Endocrinology. 2004;145(4):1649–1655.
   PubMed Web of Science ®Google Scholar
• Peeters RP, Wouters PJ, van Toor H, et al. Serum 3,3',5'-triiodothyronine (rT3) and 3,5,3'-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. J Clin Endocrinol Metab. 2005;90(8):4559–4565.
   PubMed Web of Science ®Google Scholar
• Yanni GN, Destariani CP, Lubis AN, et al. Thyroid hormone profile in children with sepsis: does euthyroid sick syndrome exist? Open Access Maced J Med Sci. 2019;7(7):1110–1113.
   PubMedGoogle Scholar
• Mohn A, Di Marzio A, Cerruto M, et al. Euthyroid sick syndrome in children with Hodgkin disease. Pediatr Hematol Oncol. 2001;18(3):211–215.
   PubMed Web of Science ®Google Scholar
• Rouphael NG, Talati NJ, Vaughan C, et al. Infections associated with hemophagocytic syndrome. Lancet Infect Dis. 2007;7(12):814–822.
   PubMed Web of Science ®Google Scholar
• Plikat K, Langgartner J, Buettner R, et al. Frequency and outcome of patients with nonthyroidal illness syndrome in a medical intensive care unit. Metab Clin Exp. 2007;56(2):239–244.
   PubMed Web of Science ®Google Scholar
• Luo B, Yu Z, Li Y. Thyroid hormone disorders and sepsis. Biomed Mater Eng. 2017;28(s1):S237–S41.
   PubMedGoogle Scholar